Psoriasis can be highly variable in morphology, distribution, and severity. Despite the classic presentation described above, the morphology can range from small tear shaped papules (guttate psoriasis ...

Guttate psoriasis, for example, typically occurs after an episode of streptococcal throat infection. She adds: “There are many environmental factors that can worsen psoriasis, e.g. trauma ...

This is the least common type of psoriasis. The skin redness is very intense and can cover your entire body with a red, peeling rash that can itch or burn intensely. Guttate. This affects people ...

Psoriasis is a chronic inflammatory disease that causes red, scaly patches on the skin, often leading to discomfort and distress. While it may appear to be a superficial issue, psoriasis is a complex ...

Every image on iStock falls into one of two collections. Our Essentials collection gives you the everyday content you need, while our Signature library features our best quality, premium handpicked ...

A clinical diagnosis was made of psoriasis and he was prescribed clobetasol propionate ointment with salicylic acid 6% in petrolatum that should be applied in the evening to his elbows and knees ...

Animal Pictures and Facts Learn all you wanted to know about animals with pictures, videos, facts, news, and more. Composite photograph by Joel Sartore, National Geographic Photo Ark ...

There is no transcript available.

A 20-year-old female with a history of guttate, inverse, and scalp psoriasis was initiated on isotretinoin for inflammatory acne. Within 3 days, she developed pruritic erythematous plaques with ...

1998; Helwig, 2000; Stein, 2000). Psoriasis affects 2% of the U.S. population, accounting for 10% of outpatient visits to dermatologists (Thompson, Feldman, & Fleischer, 1998). In a university ...

These puzzles usually consist of two almost identical images placed side by side, with the goal being to find the differences between them. The differences can vary, such as changes in colour or ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...